The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one area where AI has the most potential. Nobel prize winner and ...

Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund — just two years after its first — to hunt for startups that are using artificial ...

LON­DON — Demis Has­s­abis has no in­ter­est in a lab­o­ra­to­ry. The No­bel Prize-win­ning ar­ti­fi­cial in­tel­li­gence pi­o­neer is bet­ting big on AI’s fu­ture in drug ...

To stay competitive, labs are adopting AI-powered platforms and automation tools that streamline complex tasks, increase throughput, and enable real-time decision-making. The rise of robotics, cloud ...

q2-amrfinderplus: QIIME 2 plugin to find acquired antimicrobial resistance genes and point mutations in protein and/or assembled nucleotide sequences with AMRFinderPlus.

On July 31, the Canadian biotechnology firm AbCellera ... allowing the selective modification of the DNA of living organisms, AI is proving hugely transformational in the discovery and development of ...

In an effort to automate scientific discovery using artificial intelligence (AI), researchers have created a virtual laboratory that combines several ‘AI scientists’ — large language models ...

we must evolve our trust in AI systems," said Jonathan Dotan, Founder of EQTY Lab. "Verifiable Compute protects and controls AI data, models, and agents with the industry’s most advanced ...

Exscientia Plc, a pioneering biotechnology company leveraging artificial intelligence for drug discovery, stands at a pivotal juncture as it navigates a transformative merger and advances its ...